Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Silo Pharma, Inc. | Director | Non-Qualified Stock Option | 171K | Dec 29, 2021 | Direct | ||
DatChat, Inc. | Director | Employee Stock Option (right to buy) | 25K | Sep 28, 2021 | Direct | ||
Hoth Therapeutics, Inc. | Director | Options | 25K | Aug 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HOTH | Hoth Therapeutics, Inc. | Aug 19, 2024 | 1 | $0 | 4 | Aug 21, 2024 | Director |
HOTH | Hoth Therapeutics, Inc. | Jan 5, 2024 | 1 | $0 | 4 | Jan 8, 2024 | Director |
HOTH | Hoth Therapeutics, Inc. | Jul 17, 2023 | 1 | $0 | 4 | Jul 18, 2023 | Director |
HOTH | Hoth Therapeutics, Inc. | Mar 16, 2022 | 1 | $0 | 4 | Mar 18, 2022 | Director |
SILO | Silo Pharma, Inc. | Dec 29, 2021 | 1 | $0 | 4/A | Jan 5, 2022 | Director |
DATS | DatChat, Inc. | Sep 28, 2021 | 1 | $0 | 4 | Sep 30, 2021 | Director |
DATS | DatChat, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 20, 2021 | Director |
DATS | DatChat, Inc. | Aug 13, 2021 | 1 | $0 | 4/A | Oct 12, 2021 | Director |
DATS | DatChat, Inc. | Aug 12, 2021 | 0 | $0 | 3 | Aug 13, 2021 | Director |